Our top content for the year highlight many challenges the field of non–small cell lung cancer (NSCLC) encountered, with data ...

A team has discovered a new communication pathway between the gut and lung. Their findings highlight how a little-known member of the gut microbiome reshapes the lung immune environment to have both ...

It was a routine prescription by Dr. Bryant Lin for an otherwise typical case of gout. What was unexpected was how the patient’s skin started peeling after using the drug. The condition was ...

In addition, patients treated with approved ROS1 TKIs often develop resistance mutations to these therapies, representing a major limitation for patients in terms of duration of response. The approval ...

A series of innovations to improve care for lung cancer patients at Northumbria Healthcare NHS Foundation Trust have been ...

Changes can be identified with near-perfect precision by compact, portable scanners within a matter of hours. Different types ...

Lung cancer is a terrifying disease with the number one mortality rate not only in Korea but also worldwide.Smoking is the ...

Patients, clinicians and researchers have much to thank John A. Thompson, MD, for when he retires at the end of 2024 after 40 ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

The National Health Insurance (NHI) cannot provide the best care for people with lung cancer despite government goals to ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the ...